Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vaccine injury compensation

Executive Summary

House Government Reform/Criminal Justice, Drug Policy & Human Resources Subcommittee will hold a hearing Sept. 17 to discuss the Vaccine Injury Compensation Program. Invited witnesses include VICP Director Thomas Balbier, an un-named medical expert on vaccine injuries, a lawyer involved in vaccine injury litigation and families of those allegedly harmed. At an Aug. 3 hearing of the full committee, Subcommittee Chairman Mica (R-Fla.) requested that Surgeon General David Satcher, MD/PhD, submit recommendations to his staff on potential legislation to allocate VICP funds for vaccine safety research (1"The Pink Sheet" Aug. 9, p. 14)

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034832

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel